Rigorous Review
The new journal’s strong, experienced editorial board ensures continuity and high quality in its review process, Dr. Assassi says. ACROR’s deputy editor for clinical science is David I. Daikh, MD, PhD, director of the Rheumatology Fellowship Training Program at UCSF and chief of rheumatology for the San Francisco VA Medical Center. The deputy editor for basic science is Bruce N. Cronstein, MD, the Dr. Paul M. Esserman Professor of Medicine at New York University. ACROR’s social media editor is Paul H. Sufka, MD, a rheumatologist at HealthPartners in Saint Paul, Minn. Dr. Sufka is also social media editor for A&R and AC&R.
“It’s important for the rheumatology community to take advantage of this new resource and publish their manuscripts in this new journal. It meets the expanding needs of our community,” says Dr. Assassi.
Open-Access Benefits
All articles published in ACROR, published by John Wiley & Sons on behalf of the ACR, are accessible online for anyone to read in full, unlike many articles in A&R or AC&R, which are only accessible to read in full one year after publication without an active ACR/ARP membership or a subscription to the journal. ACROR has no paid subscriptions. Any reader may excerpt figures or tables, and share, publish or reuse the content of ACROR articles for non-commercial purposes, without copyright permission.
Authors have two paths to submit articles to ACROR, says Dr. Assassi. They may submit articles directly to the open access journal, or if they have submitted articles to A&R or AC&R that were not accepted but still considered scientifically important by those editors, authors are invited to have their article internally resubmitted to ACROR, he says. In many cases, the review used by the submission to A&R and AC&R can be used for submission to ACROR, speeding the path to publication. To cover the cost of publishing and making articles freely available, authors (or their institutions) are expected to pay a publication fee. More information about these fees is available on the journal’s website.
Creative Work
Dr. Yelin and Dr. Katz, who previously served as co-editors of AC&R, wrote an editorial, “Opening Salvo,” to launch the new journal and explain why it meets an unmet need.2 They compared the very low acceptance rates for the most prestigious journals to low pay lines for National Institutes of Health (NIH) grants. In the editorial, they wrote, “The acceptances you do receive are for good ideas well done—but perhaps not the ones that you feel are most likely to change research or practice, if they could be given a fair hearing by peer reviewers.” ACROR, according to its co-editors, offers a golden opportunity to “push the boundaries a bit by placing the mark at a slightly different point on the rigor-relevance continuum.”
Here is a snapshot of recent studies published in ACROR:
